Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cuddy

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular and Cellular Biology|August 1, 1990
Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblastsJ C Reed, S Haldar, C M Croce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosineD D Ross, D P Cuddy, N Cohen, et al.
Oncogene|September 1, 1989
Deregulated BCL2 expression enhances growth of a human B cell lineJ C Reed, S Haldar, M P Cuddy, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1996
No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trialL B Pemberton, V Ross, P Cuddy, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1991
Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenesJ C Reed, S Yum, M P Cuddy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugsD L de Valeriola, D D Ross, A Forrest, et al.
Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.
Journal of Biomolecular Screening|October 29, 2011
TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitorsCharitha Madiraju, Kate Welsh, Michael P Cuddy, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular and Cellular Biology|August 1, 1990
Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblastsJ C Reed, S Haldar, C M Croce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosineD D Ross, D P Cuddy, N Cohen, et al.
Oncogene|September 1, 1989
Deregulated BCL2 expression enhances growth of a human B cell lineJ C Reed, S Haldar, M P Cuddy, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1996
No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trialL B Pemberton, V Ross, P Cuddy, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1991
Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenesJ C Reed, S Yum, M P Cuddy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugsD L de Valeriola, D D Ross, A Forrest, et al.
Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.
Journal of Biomolecular Screening|October 29, 2011
TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitorsCharitha Madiraju, Kate Welsh, Michael P Cuddy, et al.
Pageof 2